An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study)

An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study)

Immunogenicity following an additional dose of Coronavirus disease 2019 (COVID-19) vaccine was investigated in an extended primary series among kidney transplant (KT) recipients. Eighty-five KT participants were randomized to receive either an mRNA (M group; n = 43) or viral vector (V group; n = 42)...

Full description

Saved in:
Bibliographic Details
Main Authors: Jackrapong Bruminhent, Chavachol Setthaudom, Pattaraphorn Phornkittikorn, Pongsathon Chaumdee, Somsak Prasongtanakij, Supanart Srisala, Kumthorn Malathum, Sarinya Boongird, Arkom Nongnuch, Montira Assanatham, Laor Nakgul, Nutaporn Sanmeema, Angsana Phuphuakrat, Sasisopin Kiertiburanakul
Other Authors: Faculty of Medicine Ramathibodi Hospital, Mahidol University
Format: Article
Published: 2022
Subjects:
Medicine
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/74912
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://repository.li.mahidol.ac.th/handle/123456789/74912

Similar Items